Table 3
Age-specific predicted five-year net survival (NS) estimates, by selected cancer type, Canada excluding Quebec, 2012 to 2014^{Table 3 Note †}

Table 3
Age-specific predicted five-year net survival (NS) estimates, by selected cancer type, Canada excluding Quebec, 2012 to 2014†
Table summary
This table displays the results of Age-specific predicted five-year net survival (NS) estimates. The information is grouped by Cancer (appearing as row headers), Age group at diagnosis (years), 15 to 44, 45 to 54, 55 to 64, 65 to 74, 75 to 84, 85 to 99, NS (%) and 95% confidence interval, calculated using from and to units of measure (appearing as column headers).
Cancer	Age group at diagnosis (years)
	15 to 44			45 to 54			55 to 64			65 to 74			75 to 84			85 to 99
	NS (%)	95% confidence interval		NS (%)	95% confidence interval		NS (%)	95% confidence interval		NS (%)	95% confidence interval		NS (%)	95% confidence interval		NS (%)	95% confidence interval
	NS (%)	from	to	NS (%)	from	to	NS (%)	from	to	NS (%)	from	to	NS (%)	from	to	NS (%)	from	to
Tongue	75	68	81	70	66	74	67	63	70	61	56	65	41	35	48	51^{Note E: Use with caution}	31	68
Esophagus	21	14	31	20	16	23	20	17	22	15	13	17	12	10	15	4	2	7
Stomach	34	29	39	32	28	35	30	28	33	32	30	34	26	23	28	13	10	17
Small intestine	70	60	77	67	62	72	64	59	68	57	52	61	46	39	52	29^{Note E: Use with caution}	18	41
Colon	73	70	75	69	67	71	68	66	69	67	66	68	63	62	65	55	52	58
Rectum	73	70	76	75	73	76	72	70	73	69	67	70	58	56	60	40	35	44
Anus	72	61	81	71	65	76	72	68	77	69	63	75	46	38	54	26^{Note E: Use with caution}	14	41
Liver	40	31	49	27	23	30	25	23	28	16	14	19	11	9	13	4	2	9
Pancreas	39	33	45	16	14	19	11	9	12	7	6	8	5	4	6	1	1	2
Larynx	77^{Note E: Use with caution}	62	87	71	65	76	65	61	69	61	56	65	53	46	59	60^{Note E: Use with caution}	40	75
Lung and bronchus	35	31	39	24	22	25	22	21	23	21	20	21	15	14	16	9	7	10
Soft tissue (including heart)	71	67	74	69	64	73	66	61	70	60	55	65	50	43	56	40^{Note E: Use with caution}	28	51
Melanomas of the skin	92	91	93	91	90	92	89	88	90	87	85	88	83	80	85	80	72	86
Breast	88	87	89	91	90	91	90	90	91	91	90	92	83	82	85	75	71	78
Cervix uteri	86	84	87	72	69	75	64	60	68	53	47	59	44	36	52	38^{Note E: Use with caution}	21	55
Uterus (body, NOS)	90	87	92	88	87	90	88	87	89	82	80	83	73	70	76	58	49	65
Ovary	77	73	80	64	61	67	52	49	55	35	32	38	23	20	26	10	6	14
Prostate	95	90	98	97	96	97	97	97	97	97	96	97	87	85	88	57	53	61
Testis	97	96	98	97	93	99	93	84	97	96^{Note E: Use with caution}	30	100	Note F: too unreliable to be published	Note F: too unreliable to be published	Note F: too unreliable to be published	Note F: too unreliable to be published	Note F: too unreliable to be published	Note F: too unreliable to be published
Bladder (including in situ)^{Table 3 Note ‡}	89	85	92	87	84	89	82	80	83	79	77	80	70	68	72	57	53	62
Kidney and renal pelvis	88	86	90	82	80	84	77	76	79	70	68	72	59	56	62	33	28	39
Brain	61	58	64	27	24	30	12	11	14	7	5	9	2	1	3	2	0	5
Thyroid	100	99	100	99	98	99	97	96	98	95	93	97	91	85	95	Note F: too unreliable to be published	Note F: too unreliable to be published	Note F: too unreliable to be published
Hodgkin lymphoma	96	95	97	92	88	95	80	74	86	61	53	68	48^{Note E: Use with caution}	37	59	Note F: too unreliable to be published	Note F: too unreliable to be published	Note F: too unreliable to be published
Non-Hodgkin lymphoma	84	82	86	81	79	83	77	76	79	70	68	71	57	55	59	40	35	44
Multiple myeloma	77	68	83	62	57	66	57	54	60	47	44	50	35	31	38	16	12	21
Chronic lymphocytic leukemia	93	85	97	96	93	97	92	90	94	86	84	89	75	71	78	61	52	69
Acute myeloid leukemia	62	57	67	44	39	50	24	21	28	10	8	13	3	2	6	3	1	8
Chronic myeloid leukemia	93	89	96	90	84	94	73	67	78	57	50	63	37	30	44	12^{Note E: Use with caution}	5	24
Mesothelioma	Note F: too unreliable to be published	Note F: too unreliable to be published	Note F: too unreliable to be published	8	2	18	12	7	19	7	5	10	7	4	10	1	0	10
^E use with caution F too unreliable to be published Note † data from Quebec have not been submitted to the Canadian Cancer Registry since the 2010 data year; NS estimates predicted using the period method Return to note † referrer Note ‡ the province of Ontario did not submit in situ bladder cancer cases to the Canadian Cancer Registry prior to the 2010 data year Return to note ‡ referrer NOS=not otherwise specified Sources: Canadian Cancer Registry death linked file (1992-2014); life tables.

Date modified:: 2018-09-19

Language selection

Search and menus

Search

Table 3
Age-specific predicted five-year net survival (NS) estimates, by selected cancer type, Canada excluding Quebec, 2012 to 2014^{Table 3 Note †}

Table 3 Age-specific predicted five-year net survival (NS) estimates, by selected cancer type, Canada excluding Quebec, 2012 to 2014Table 3 Note †

Note of appreciation

Standards of service to the public

Copyright

Table 3
Age-specific predicted five-year net survival (NS) estimates, by selected cancer type, Canada excluding Quebec, 2012 to 2014^{Table 3 Note †}